News · 26 weeks50+100%
2026-03-012026-08-23
Mix2790d
- Other13(48%)
- SEC Filings11(41%)
- Insider3(11%)
Latest news
25 items- SECSEC Form DEFA14A filed by BIO-key International Inc.DEFA14A - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- SECSEC Form PRE 14A filed by BIO-key International Inc.PRE 14A - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- SECBIO-key International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRBIO-key’s Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally; Call Tomorrow at 10am ETHOLMDEL, N.J., Aug. 13, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced its second quarter (Q2’26) and first half (1H’26) results and provided its outlook for the second half of 2026 (2H’26). BIO-key will host an investor call tomorrow at 10:00am ET (details below). Financial Highlights Q2’26 revenues increased 13% to $1.9MApproximately $0.8M in fully-reserved hardware revenue with a 100% gross profit contribution was anticipated in Q2’26 but was delayed and is now anticipated in 2H’26.Q2’26 gross margin improved to 87% vs. 73% in Q2'25,reflecting the increase
- SECBIO-key International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- SECSEC Form 10-Q filed by BIO-key International Inc.10-Q - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRBIO-key International Enters into $2.5 Million Warrant Inducement TransactionHOLMDEL, N.J., Aug. 11, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global innovator in Identity and Access Management (IAM) and biometric authentication solutions, today announced it has entered into a warrant inducement agreement with an existing institutional investor for the exercise of certain outstanding warrants that the Company issued on October 28, 2025 (the "Warrants"). Pursuant to the warrant inducement agreement, the investor has agreed to exercise the Warrants to purchase an aggregate of 618,334 shares of the Company's common stock at a reduced exercise price of $4.06 per share, subject to compliance with beneficial ownership blocker provisions includ
- PRPortuguese National Security Agency Selects BIO-key and Visualforma to Strengthen Identity SecurityFARO, Portugal and HOLMDEL, N.J., Aug. 10, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global innovator in Identity and Access Management (IAM) and biometric authentication solutions, today announced that, together with its strategic Portuguese partner Visualforma, it has been awarded a new contract to strengthen digital identity security for a Portuguese national security agency. The award is a significant expansion of BIO-key’s and Visualforma’s long-standing collaboration within the Portuguese public sector. Following successful deployments across government organizations and municipalities, it now extends into one of the country’s most security-sensitive envi
- PRAdvanced Authentication Solutions Provider BIO-key Hosts Q2 Investor Call Friday, August 14th at 10am ETHOLMDEL, N.J., Aug. 07, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management and biometric authentication technologies, will host its Q2’26 investor call and webcast on Friday, August 14th at 10 a.m. ET. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the call and Q&A session. Call/Webcast Details Date / Time:Friday, August 14th at 10 a.m. ETCall Dial In #:1-877-418-5460 U.S. or 1-412-717-9594 Int’lLive Webcast / Replay:Webcast & Replay Link – Available for 3 months.Audio Replay:1-855-669-9658 U.S. or 1-412-317-0088 Int’l; code 7314992 About BIO-key International, Inc. (www.BIO-key.com) BIO-key is revolution
- PRBIO-key and Maktabi Tech Partner to Advance Identity Security Across Saudi Arabia’s Education SectorRIYADH, Saudi Arabia and HOLMDEL, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global innovator in Identity and Access Management (IAM) and Identity-Bound Biometrics, today announced a strategic partnership with Maktabi Tech, a leading regional technology company specializing in digital transformation and cybersecurity solutions for the education sector across Saudi Arabia, Jordan, and the United Arab Emirates. The partnership brings BIO-key’s award-winning PortalGuard Identity and Access Management platform—including Multi-Factor Authentication (MFA), Single Sign-On (SSO), passwordless authentication, and Identity-Bound Biometrics—to educational
- PRCentral Bank of Jordan Selects BIO-key for National Biometric Authentication InitiativeAMMAN, Jordan and HOLMDEL, N.J., July 28, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global leader in biometric-powered identity and access management (IAM), today announced that the Central Bank of Jordan (CBJ) is working with BIO-key on a national initiative to modernize how end clients authenticate across Jordan’s financial sector, which serves a total population of 11.6 million. The CBJ initiative reflects a broader move toward biometric-first authentication, with the objective of reducing and ultimately eliminating end-client dependency on passwords, tokens and other traditional credentials and their related costs. By tying authentication directly to an ind
- SECSEC Form DEF 14A filed by BIO-key International Inc.DEF 14A - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- SECBIO-key International Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- SECBIO-key International Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRBIO-key Regains Compliance with Nasdaq Listing Rules; Nasdaq Trading Resumes on Wednesday, July 8thHOLMDEL, N.J., July 07, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management and biometric authentication technologies, today announced that The Nasdaq Stock Market LLC has notified it that the trading of its common stock will recommence on the Nasdaq Capital Market effective with markets’ opening on Wednesday, July 8, 2026. Trading of BIO-key’s shares was restored following a June 16th hearing with a Nasdaq Hearings Panel, in which the Panel determined the Company has regained compliance with the continued listing standards, including minimum bid price and SEC filing requirements. The Company will be subject to a Discretio
- INSIDERChief Legal Officer Sullivan James David was granted 250 shares, increasing direct ownership by 3% to 9,986 units (SEC Form 4)4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
- INSIDERChief Executive Officer Depasquale Michael W was granted 250 shares, increasing direct ownership by 2% to 10,778 units (SEC Form 4)4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
- INSIDERChief Technology Officer Lacous Mira K was granted 250 shares, increasing direct ownership by 7% to 4,076 units (SEC Form 4)4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
- PRBIO-key Showcases Passwordless & Biometric Identity Solutions at Jordan Banking Cybersecurity Workshop in Amman on July 6thAMMAN, Jordan and MADRID, July 02, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (OTCQB:BKYI), a global leader in biometric-powered identity and access management (IAM), will participate in an invitation-only cybersecurity and identity workshop hosted in Amman by the Association of Banks in Jordan on July 6th. The invitation-only government-sponsored event brings together cybersecurity, IT, digital transformation, and management leaders from leading banks and financial institutions across Jordan to address cyber threats, identity security challenges, modern authentication strategies and IT return-on-investment. Over 25 institutions, including C-level executives, have confirmed att
- SECSEC Form 10-Q filed by BIO-key International Inc.10-Q - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRBIO-key's Fireside Chat at Maxim Group Defense Tech Conf. to Webcast Thur. June 25 at 4pm ETHOLMDEL, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (OTC Markets: BKYI), a provider of biometric authentication technologies used by leading military and defense ministries, announced that its CEO Michael DePasquale will participate in a webcast fireside chat at Maxim Group's Defense Tech Virtual Conference, Thursday, June 25, 2026 at 4:00 pm ET (Track 2). The conversation will be led by Maxim Group Equity Analyst Jack Vander Aarde, including Q&A. Growing global tensions along with increasing incidents of military action are exposing a range of challenges to traditional strategies. In this virtual conference, Maxim Group Research Analysts sit down with company le
- SECSEC Form 10-K filed by BIO-key International Inc.10-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- SECBIO-key International Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
- PRBIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-Q FilingHOLMDEL, N.J., June 10, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (OTC Markets: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced today that it has received a notification letter from The Nasdaq Stock Market, LLC informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission, due to the Company's failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026. In the notice, Nasdaq further informed the Company that the Nasdaq Heari
- PRBIO-key's RedChip Future Tech Investor Conference Presentation to be Webcast Wed. June 10 at 3pm ETHOLMDEL, N.J., June 04, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (OTC Markets: BKYI), a global leader in Identity and Access Management and biometric authentication technologies, today announced that Michael DePasquale, Chairman and CEO, will present online at the RedChip Future Tech Investor Conference: Profiting from Technologies, Transforming Work, Life, and Industry, Wednesday, June 10, 2026 at 3:00 pm ET, followed by a live question-and-answer session. The virtual event provides investors direct access to executive management teams at companies driving innovation across artificial intelligence, automation, digital infrastructure, advanced manufacturing, enterprise softwar
BKYI FAQ
5 questionsWhat does BIO-key International Inc. do?
BIO-key International, Inc., together with its subsidiaries, develops and markets fingerprint identification biometric technology, enterprise-ready identity access management solutions, and software solutions to commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premise SaaS application, as well as windows device authentication through IAM platform. Its...Where does BKYI stock trade?
BIO-key International Inc. (BKYI) is listed on NASDAQ.What sector and industry is BKYI in?
BIO-key International Inc. operates in the Technology sector, Computer Software: Prepackaged Software industry.What companies are similar to BKYI?
Notable peers in the same industry include MSFT (Microsoft Corporation), ORCL (Oracle Corporation), SAP (SAP SE), CRWD (CrowdStrike Holdings Inc.), CRM (Salesforce Inc.). Compare BKYI side-by-side with any of them on Quantisnow.How can I track BKYI on Quantisnow?
Quantisnow aggregates BIO-key International Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BKYI to receive live email and push alerts on every new disclosure.